DarioHealth Corp.: 10-Q filed 2013-08-14
What DarioHealth Corp. reported in its quarterly report filed 2013-08-14 (fiscal Q2 2013): 21 published measures, 77 facts as tagged in accession 0001144204-13-045604.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2013-08-14
- Fiscal period
- fiscal Q2 2013
- Accession
- 0001144204-13-045604 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All DarioHealth Corp. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 9,401,436 | USD | |
| At 2012-12-31 | 2,315,453 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 1,841,966 | USD | |
| At 2013-03-31 | -4,085,618 | USD | |
| At 2012-12-31 | -1,069,043 | USD | |
| At 2011-12-31 | 193,144 | USD | |
| At 2011-08-10 | 0 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 7,025,282 | USD | |
| At 2012-12-31 | 1,230,034 | USD | |
| At 2012-06-30 | 1,007,259 | USD | |
| At 2011-12-31 | 908,765 | USD | |
| At 2011-08-10 | 0 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | -5,286,472 | USD | 91 |
| 2013-01-01 to 2013-06-30 | -10,513,341 | USD | 181 |
| 2011-08-11 to 2013-06-30 | -16,585,263 | USD | 690 |
| 2013-01-01 to 2013-03-31 | -5,226,869 | USD | 90 |
| 2012-01-01 to 2012-12-31 | -5,686,573 | USD | 366 |
| 2012-04-01 to 2012-06-30 | -867,230 | USD | 91 |
| 2012-01-01 to 2012-06-30 | -1,438,113 | USD | 182 |
| 2011-08-11 to 2011-12-31 | -385,349 | USD | 143 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-06-30 | -3,021,454 | USD | 181 |
| 2011-08-11 to 2013-06-30 | -6,055,641 | USD | 690 |
| 2012-01-01 to 2012-06-30 | -795,267 | USD | 182 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-06-30 | 1,146,480 | USD | 181 |
| 2011-08-11 to 2013-06-30 | 1,788,665 | USD | 690 |
| 2012-01-01 to 2012-06-30 | 22,082 | USD | 182 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-06-30 | 10,146,093 | USD | 181 |
| 2011-08-11 to 2013-06-30 | 15,116,450 | USD | 690 |
| 2012-01-01 to 2012-06-30 | 915,845 | USD | 182 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-06-30 | -1,329,391 | USD | 181 |
| 2011-08-11 to 2013-06-30 | -2,035,527 | USD | 690 |
| 2012-01-01 to 2012-06-30 | -22,082 | USD | 182 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 1,486,426 | USD | |
| At 2012-12-31 | 617,364 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | 279,607 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 1,358,540 | USD | 181 |
| 2011-08-11 to 2013-06-30 | 1,748,943 | USD | 690 |
| 2012-04-01 to 2012-06-30 | 166,211 | USD | 91 |
| 2012-01-01 to 2012-06-30 | 292,804 | USD | 182 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | -3,596,074 | USD | 91 |
| 2013-01-01 to 2013-06-30 | -6,672,241 | USD | 181 |
| 2011-08-11 to 2013-06-30 | -10,881,362 | USD | 690 |
| 2012-04-01 to 2012-06-30 | -866,349 | USD | 91 |
| 2012-01-01 to 2012-06-30 | -1,361,095 | USD | 182 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 7,807,400 | USD | |
| At 2012-12-31 | 1,666,544 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 1,326,917 | USD | |
| At 2012-12-31 | 566,755 | USD |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | 1,415,805 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 2,091,219 | USD | 181 |
| 2011-08-11 to 2013-06-30 | 3,670,379 | USD | 690 |
| 2012-04-01 to 2012-06-30 | 449,148 | USD | 91 |
| 2012-01-01 to 2012-06-30 | 620,818 | USD | 182 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 19,965,079 | shares | |
| At 2012-12-31 | 14,547,689 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 18,425,233 | USD | |
| At 2012-12-31 | 5,001,425 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 654,306 | USD | |
| At 2012-12-31 | 401,522 | USD |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | 1,516,206 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 3,419,931 | USD | 181 |
| 2011-08-11 to 2013-06-30 | 5,753,905 | USD | 690 |
| 2012-04-01 to 2012-06-30 | 417,201 | USD | 91 |
| 2012-01-01 to 2012-06-30 | 740,277 | USD | 182 |
Depreciation expense
Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-06-30 | 313,702 | USD | 181 |
| 2011-08-11 to 2013-06-30 | 338,523 | USD | 690 |
| 2012-01-01 to 2012-06-30 | 3,681 | USD | 182 |
Other nonoperating income or expense
Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | -26,418 | USD | 91 |
| 2013-01-01 to 2013-06-30 | -41,123 | USD | 181 |
| 2011-08-11 to 2013-06-30 | -56,053 | USD | 690 |
| 2012-04-01 to 2012-06-30 | -6,203 | USD | 91 |
| 2012-01-01 to 2012-06-30 | -2,195 | USD | 182 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | -1,690,398 | USD | 91 |
| 2013-01-01 to 2013-06-30 | -3,841,100 | USD | 181 |
| 2011-08-11 to 2013-06-30 | -5,703,901 | USD | 690 |
| 2012-04-01 to 2012-06-30 | -881 | USD | 91 |
| 2012-01-01 to 2012-06-30 | -77,018 | USD | 182 |
Inspect the source
- Entity
- DarioHealth Corp. / CIK 0001533998
- Captured
- 2026-09-20T09:16:34.053Z
- SEC response SHA-256
8c524c61fa46c2531eea7286cfb0614b41c397fc0b2f416d3e5df141148eb6b9
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001533998.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))